Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00664664 | Subjective Study to Assess the Efficacy of APD125 in Patients With Sleep Maintenance Insomnia | PHASE2 | COMPLETED | 744 | — | — | Apr 1, 2008 | Nov 1, 2008 | Dec 23, 2020 | - | — |
| Name | Type | Description |
|---|---|---|
| APD125 | DRUG | soft gelatin capsule, 20 mg, daily dosing for up to 3 weeks |
| Placebo | DRUG | soft gelatin capsule, daily dosing for up to 3 weeks |